An NSF International Company

Industry news

NSF Health Sciences experts bring you the latest news updates from the industry

CDSCO (India) Announced That Imported Drug Products Must Meet Indian Medicinal Products Requirements

Tuesday the 18th March 2014

The Indian drug regulatory agency Central Drugs Standard Control Organization (CDSCO) announced on March 4 that drug products imported into India must comply with Indian requirements for the manufacture of medicinal products.

CDSCO has increased surveillance of medical products imported into India in an effort to safeguard public health and to help ensure product efficacy and safety. In an official announcement, the CDSCO stated “It has been decided that the drugs for import into the country shall be allowed only if these are in compliance to the requirements of the Drugs & Cosmetics Act, 1940 and Drugs & Cosmetics Rules, 1945.” Compliance may be demonstrated through product testing and/or independent audits of manufacturing facilities prior to import.

See notice

    Quick links

    NSF Health Sciences have offices in Kirkbymoorside and Sheffield, UK and Washington and Ann Arbor, USA

    A word from NSF Health Sciences

    The legislation and guidance that apply to the healthcare industries is forever changing. NSF Health Sciences will provide you with regular updates on what is new and will also provide you with expert interpretation of these changes - what they mean

    Peter Gough

    © NSF Health Sciences 2015

    Registered Office: NSF Health Sciences, The Georgian House, 22/24 West End, Kirkbymoorside, York, UK, YO62 6AF
    Registered in England and Wales No: 3432550 | Tel: +44(0)1751 432999 | Fax: +44(0)1751 432450 | Email: [email protected]
    US Office: NSF Health Sciences, 2001 Pennsylvania Ave, NW, Suite 950, Washington DC 20006 | Tel: 1-202-822-1850 | Fax: 1-202-822-1859 | Email: [email protected]